Noura Radwan
Papers
1
Total Citations
2
H-Index
1
About
Noura Radwan is a radiation oncologist whose research focuses on the application of advanced radiotherapy techniques in the management of prostate cancer, with a particular emphasis on stereotactic ablative radiation therapy (SABR) for oligometastatic disease. Her most-cited work, a 2016 study on SABR for oligometastatic prostate cancer, has garnered 2 citations and contributes to the growing body of evidence supporting the use of high-precision, ablative doses in treating limited metastatic spread. While her citation count is modest, Radwan’s research is situated at the intersection of technological innovation and clinical oncology, exploring how targeted radiation can improve outcomes for patients with metastatic prostate cancer. Her work underscores the potential of SABR to delay disease progression and enhance quality of life, reflecting a broader shift toward personalized, metastasis-directed therapies. Radwan’s contributions are particularly relevant for researchers and clinicians interested in the evolving role of radiation oncology in the era of precision medicine, where her findings help inform treatment paradigms for a challenging patient population.
Research Focus
Key Achievements
Top Papers
- 1